Hemoccult screening for colorectal cancer has significant weaknesses, including low sensitivity for polyps and cancer. Its cost-effectiveness and survival benefits for asymptomatic individuals are not sufficiently proven.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: